Thursday, October 1News That Matters
Shadow

F.D.A. EXPEDITES REVIEW OF AMERICAN HOME'S CANCER DRUG

F.D.A. EXPEDITES REVIEW OF AMERICAN HOME’S CANCER DRUG

American Home Products Corp says Food and Drug Administration will give expedited review to its experimental treatment for kidney cancer; FDA will review experimental drug, known as CCI-779, as treatment for renal-cell carcinoma after initial ther…

Read More…



Leave a Reply

Your email address will not be published. Required fields are marked *